In our study, we observed that the expression of NFE2L2, also known as nrf2, was lower in NAFLD samples than that in control liver samples, indicating a negative correlation between NFE2L2 expression and NAFLD. Here, NFE2L2 is linked to metabolic dysfunction-associated steatotic liver disease.